Literature DB >> 11961322

Metachronous germinoma after total removal of mature teratoma in the third ventricle: a case report.

Jae Min Kim1, Jin Hwan Cheong, Hyeong Joong Yi, Koang Hum Bak, Choong Hyun Kim, Suck Jun Oh.   

Abstract

A rare case of intraventricular germinoma in the third ventricle, which occurred 30 months after total removal of mature teratoma on the same location in a 29- yr-old man is presented. Recurrence is supposed to represent an acceleration of localized dysplastic processes of totipotent germ cells present in the midline neuraxis or a growth of unidentified microscopic residue of germinoma component in mature teratoma. Although the radiation therapy after total removal of mature teratoma is still controversial, careful follow-up is warranted for evaluating a possible recurrence of other germ cell tumors.

Entities:  

Mesh:

Year:  2002        PMID: 11961322      PMCID: PMC3054861          DOI: 10.3346/jkms.2002.17.2.287

Source DB:  PubMed          Journal:  J Korean Med Sci        ISSN: 1011-8934            Impact factor:   2.153


  4 in total

1.  Occurrence of a germinoma 22 years after resection of a mature cerebral teratoma.

Authors:  Wibke G Janzarik; Klaus Müller; Michael Lübbert; Joachim Spreer; Michael Trippel; Inge Uhlig; Cornelius Weiller; Sebastian Rauer
Journal:  J Neurooncol       Date:  2008-06       Impact factor: 4.130

2.  Germinoma with Diffuse Subependymal Spread: A Case Report.

Authors:  Evan M Krueger; Darbi L Invergo; Julian J Lin
Journal:  Cureus       Date:  2016-06-15

3.  Large Mature Cystic Teratoma of the Third Ventricle in Infancy: A Case Report and Review of Literatures.

Authors:  Byeong Jin Ha; Young Soo Kim; Jin Hwan Cheong
Journal:  Brain Tumor Res Treat       Date:  2016-04-29

4.  Rare sphenoid ridge intracranial mature teratoma in an adult female.

Authors:  Moses Osaodion Inojie; Yota Suzuki; Hisashi Tamada; Naoki Ogihara; Yuki Inomata; Takehiro Yako; Samuel Chukwunoyerem Ohaegbulam; Tetsuyoshi Horiuchi
Journal:  Nagoya J Med Sci       Date:  2021-05       Impact factor: 1.131

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.